Combination MET- and EGFR-directed therapy in MET-overexpressing non-small cell lung cancers: time to move on to better biomarkers?

Por Santini, Fernando C., Kunte, Siddharth, Drilon, Alexander
Publicado no Transl Lung Cancer Res (2017)

The activity, safety, and evolving role of brigatinib in patients with ALK-rearranged non-small cell lung cancers

Por Sabari, Joshua K, Santini, Fernando C, Schram, Alison M, Bergagnini, Isabella, Chen, Ruqin, Mrad, Chebli, Lai, W Victoria, Arbour, Kathryn C, Drilon, Alexander
Publicado no Onco Targets Ther (2017)